{"transactions":[{"id":747350,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":40779,"kind":"person","name":"McKinley Kate","position":1,"cik":"0001979211","reported_name":"McKinley Kate","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T22:20:33.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":805500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from April 1, 2026, subject to the Reporting Person's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through each such vesting date."}],"balance_after":805500,"derivative":{"exercise_price":0.875,"expiration_date":"2036-06-02","underlying":"Class A Common Stock","underlying_shares":805500},"source":{"system":"sec-edgar","filing":"0001979211-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000197921126000003/ownership.xml","form_type":"4"}},{"id":1073750,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":40779,"kind":"person","name":"McKinley Kate","position":1,"cik":"0001979211","reported_name":"McKinley Kate","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-05T20:12:53.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120000,"derivative":{"exercise_price":0.528,"exercise_date":"2025-11-01","expiration_date":"2035-07-31","underlying":"Class A Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001415889-25-021027","document":"form4-08052025_080849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000141588925021027/form4-08052025_080849.xml","form_type":"4"}},{"id":1134664,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":40779,"kind":"person","name":"McKinley Kate","position":1,"cik":"0001979211","reported_name":"McKinley Kate","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T22:20:45.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from May 23, 2025."}],"balance_after":325000,"derivative":{"exercise_price":0.6168,"expiration_date":"2035-05-22","underlying":"Class A Common Stock","underlying_shares":325000},"source":{"system":"sec-edgar","filing":"0000950170-25-077200","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017025077200/ownership.xml","form_type":"4"}},{"id":1330414,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":40779,"kind":"person","name":"McKinley Kate","position":1,"cik":"0001979211","reported_name":"McKinley Kate","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-16T23:00:49.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":17960,"price":1.67,"value":29993.2,"ownership":{"direct":true},"balance_after":17960,"source":{"system":"sec-edgar","filing":"0000950170-24-136787","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017024136787/ownership.xml","form_type":"4"}},{"id":1562947,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":40779,"kind":"person","name":"McKinley Kate","position":1,"cik":"0001979211","reported_name":"McKinley Kate","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-23T01:25:17.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":323500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024."}],"balance_after":323500,"derivative":{"exercise_price":3.6,"expiration_date":"2034-03-20","underlying":"Class A Common Stock","underlying_shares":323500},"source":{"system":"sec-edgar","filing":"0000950170-24-035576","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017024035576/ownership.xml","form_type":"4"}},{"id":1704037,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":40779,"kind":"person","name":"McKinley Kate","position":1,"cik":"0001979211","reported_name":"McKinley Kate","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:09.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vest on May 22, 2024; and 1/48th of the shares subject to the option vest monthly over the remaining three years."}],"balance_after":250000,"derivative":{"exercise_price":2.84,"expiration_date":"2033-05-21","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-23-071475","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071475/ownership.xml","form_type":"4"}},{"id":1704036,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":40779,"kind":"person","name":"McKinley Kate","position":1,"cik":"0001979211","reported_name":"McKinley Kate","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:09.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vest on May 22, 2024; and 1/48th of the shares subject to the option vest monthly over the remaining three years."}],"balance_after":0,"derivative":{"exercise_price":4.13,"expiration_date":"2033-05-21","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-23-071475","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071475/ownership.xml","form_type":"4"}},{"id":1812630,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":40779,"kind":"person","name":"McKinley Kate","position":1,"cik":"0001979211","reported_name":"McKinley Kate","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-08T20:10:09.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest 25% on May 22, 2024 and 1/48th of the shares subject to the option vest monthly thereafter over the following three years."}],"balance_after":250000,"derivative":{"exercise_price":4.13,"expiration_date":"2033-05-21","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-23-017839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000089924323017839/doc4.xml","form_type":"4"}}]}